Beyond Air Inc (XAIR) posted record quarterly revenue of $2.3 million and positive gross margin while awaiting FDA approval of its second-generation LungFit PH system.
Tipranks Press Release.
Detailed price information for Beyond Air Inc (XAIR-Q) from The Globe and Mail including charting and trades.
GARDEN CITY, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that its management team will participate in the 2026 Cantor Global Healthcare Conference, which is being held at the Waldorf Astoria New York, New York on September 9-11, 2026. Fireside Chat Details:Date: Thursday, September 10thTime: 3:55 PM EDT Webc
Beyond Air to receive shares representing 19.99% of Univo's issued and outstanding share capital upon closing Beyond Air eligible to receive up to $32.5 million in development and commercial milestone payments GARDEN CITY, N.Y., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) today announced that they have entered into a definitive agreement under which UNIVO Pharmaceutical Industries Ltd (“UNIVO”) Univo Pharmaceutical Industries Ltd. ("UNIVO"), a public company whose shares ar
This is the newest page. Registered accounts read further back.